Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3687)
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
1,604
Price
$265.54
Total Value
$425.92K
Shares Held After
104,796
% of Holdings
1.5%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
900
Price
$264.60
Total Value
$238.14K
Shares Held After
106,400
% of Holdings
0.8%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
62
Price
$263.05
Total Value
$16.31K
Shares Held After
107,300
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
373
Price
$271.09
Total Value
$101.12K
Shares Held After
0
% of Holdings
100.0%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
370
Price
$269.83
Total Value
$99.84K
Shares Held After
373
% of Holdings
49.8%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
3,963
Price
$268.97
Total Value
$1.07M
Shares Held After
743
% of Holdings
84.2%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
6,671
Price
$268.04
Total Value
$1.79M
Shares Held After
4,706
% of Holdings
58.6%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
11,673
Price
$266.97
Total Value
$3.12M
Shares Held After
11,377
% of Holdings
50.6%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
8,986
Price
$266.18
Total Value
$2.39M
Shares Held After
23,050
% of Holdings
28.0%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
3,557
Price
$265.08
Total Value
$942.88K
Shares Held After
32,036
% of Holdings
10.0%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
1,733
Price
$264.12
Total Value
$457.73K
Shares Held After
35,593
% of Holdings
4.6%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
569
Price
$262.91
Total Value
$149.59K
Shares Held After
37,326
% of Holdings
1.5%
Voyager Therapeutics, Inc. (VYGR)
Carter Todd Alfred — Chief Scientific Officer
Shares
4,174
Price
$3.76
Total Value
$15.69K
Shares Held After
145,718
% of Holdings
2.8%
Voyager Therapeutics, Inc. (VYGR)
Swartz Robin — COO & CBO
Shares
6,458
Price
$3.77
Total Value
$24.35K
Shares Held After
199,738
% of Holdings
3.1%
Voyager Therapeutics, Inc. (VYGR)
Sandrock Alfred — Director
Shares
14,197
Price
$3.79
Total Value
$53.81K
Shares Held After
484,060
% of Holdings
2.8%
Voyager Therapeutics, Inc. (VYGR)
Jorgensen Nathan D. — Chief Financial Officer
Shares
4,668
Price
$3.77
Total Value
$17.60K
Shares Held After
151,416
% of Holdings
3.0%
CODEXIS, INC. (CDXS)
Lutz Stefan — Chief Scientific Officer
Shares
5,862
Price
$1.13
Total Value
$6.64K
Shares Held After
130,421
% of Holdings
4.3%
Cocrystal Pharma, Inc. (COCP)
FROST PHILLIP MD ET AL — Director
Shares
20,000
Price
$1.00
Total Value
$19.95K
Shares Held After
1,908,551
% of Holdings
1.0%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
41,666
Price
$6.25
Total Value
$260.62K
Shares Held After
1,836,153
% of Holdings
2.2%
INSMED Inc (INSM)
Smith Michael Alexander — Chief Legal Officer
Shares
15,771
Price
$156.53
Total Value
$2.47M
Shares Held After
51,871
% of Holdings
23.3%
INSMED Inc (INSM)
Smith Michael Alexander — Chief Legal Officer
Shares
4,151
Price
$155.06
Total Value
$643.65K
Shares Held After
67,642
% of Holdings
5.8%
INSMED Inc (INSM)
Smith Michael Alexander — Chief Legal Officer
Shares
4,852
Price
$153.93
Total Value
$746.87K
Shares Held After
71,793
% of Holdings
6.3%
Caribou Biosciences, Inc. (CRBU)
Kelly Timothy P — Chief Technology Officer
Shares
3,147
Price
$1.96
Total Value
$6.17K
Shares Held After
79,353
% of Holdings
3.8%
Caribou Biosciences, Inc. (CRBU)
Khan Ruhi Ahmad — Chief Business Officer
Shares
6,938
Price
$1.96
Total Value
$13.60K
Shares Held After
104,998
% of Holdings
6.2%
Caribou Biosciences, Inc. (CRBU)
MCCLUNG BARBARA G — Chief Legal Officer
Shares
6,938
Price
$1.96
Total Value
$13.60K
Shares Held After
481,564
% of Holdings
1.4%
Caribou Biosciences, Inc. (CRBU)
Albertson Tina M. — Chief Medical Officer
Shares
1,066
Price
$1.96
Total Value
$2.09K
Shares Held After
68,523
% of Holdings
1.5%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
736
Price
$18.15
Total Value
$13.36K
Shares Held After
325,059
% of Holdings
0.2%
Ovid Therapeutics Inc. (OVID)
ALEXANDER MARGARET A. — Director
Shares
11,656
Price
$1.45
Total Value
$16.90K
Shares Held After
61,750
% of Holdings
15.9%
Ovid Therapeutics Inc. (OVID)
Rona Jeffrey A — CBFO
Shares
8,541
Price
$1.45
Total Value
$12.38K
Shares Held After
88,188
% of Holdings
8.8%
Candel Therapeutics, Inc. (CADL)
Manning Paul B — Director
Shares
550,458
Price
$5.45
Total Value
$3.00M
Shares Held After
2,763,527
% of Holdings
19.9%
Vera Therapeutics, Inc. (VERA)
Skelton Laurence Matthew — Chief Commercial Officer
Shares
1,582
Price
$41.98
Total Value
$66.42K
Shares Held After
64,218
% of Holdings
2.4%
Vera Therapeutics, Inc. (VERA)
Brenner Robert — Chief Medical Officer
Shares
2,151
Price
$41.98
Total Value
$90.31K
Shares Held After
50,947
% of Holdings
4.1%
Vera Therapeutics, Inc. (VERA)
Grant Sean — CHIEF FINANCIAL OFFICER
Shares
4,949
Price
$41.98
Total Value
$207.78K
Shares Held After
114,181
% of Holdings
4.2%
Vera Therapeutics, Inc. (VERA)
Turner William D. — Chief Regulatory Officer
Shares
2,187
Price
$41.98
Total Value
$91.82K
Shares Held After
45,313
% of Holdings
4.6%
Vera Therapeutics, Inc. (VERA)
JOHNSON DAVID LEE — Chief Operating Officer
Shares
2,579
Price
$41.98
Total Value
$108.28K
Shares Held After
45,727
% of Holdings
5.3%
Vera Therapeutics, Inc. (VERA)
Young Joseph R — SVP, FINANCE, CHIEF ACCT OFFCR
Shares
3,117
Price
$41.98
Total Value
$130.86K
Shares Held After
64,722
% of Holdings
4.6%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
16,925
Price
$41.98
Total Value
$710.58K
Shares Held After
257,163
% of Holdings
6.2%
OCULAR THERAPEUTIX, INC (OCUL)
Dugel Pravin — Director
Shares
20,056
Price
$8.28
Total Value
$166.06K
Shares Held After
3,013,022
% of Holdings
0.7%
OCULAR THERAPEUTIX, INC (OCUL)
Heier Jeffrey S. — Chief Scientific Officer
Shares
3,057
Price
$8.28
Total Value
$25.31K
Shares Held After
323,368
% of Holdings
0.9%
OCULAR THERAPEUTIX, INC (OCUL)
Kaiser Peter — Chief Development Officer
Shares
2,810
Price
$8.28
Total Value
$23.27K
Shares Held After
269,108
% of Holdings
1.0%
OCULAR THERAPEUTIX, INC (OCUL)
Nayak Sanjay — Chief Strategy Officer
Shares
1,759
Price
$8.28
Total Value
$14.56K
Shares Held After
330,653
% of Holdings
0.5%
Scholar Rock Holding Corp (SRRK)
Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Shares
200
Price
$48.48
Total Value
$9.70K
Shares Held After
98,445
% of Holdings
0.2%
Scholar Rock Holding Corp (SRRK)
Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Shares
857
Price
$47.86
Total Value
$41.01K
Shares Held After
98,645
% of Holdings
0.9%
Scholar Rock Holding Corp (SRRK)
Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Shares
7,427
Price
$46.94
Total Value
$348.64K
Shares Held After
99,502
% of Holdings
6.9%
ARVINAS, INC. (ARVN)
Teel Randy — Director
Shares
3,748
Price
$12.16
Total Value
$45.58K
Shares Held After
149,696
% of Holdings
2.4%
ARVINAS, INC. (ARVN)
Teel Randy — Director
Shares
1,038
Price
$12.16
Total Value
$12.62K
Shares Held After
153,444
% of Holdings
0.7%
ARVINAS, INC. (ARVN)
Cacace Angela M — Chief Scientific Officer
Shares
2,571
Price
$12.16
Total Value
$31.26K
Shares Held After
147,623
% of Holdings
1.7%
ARVINAS, INC. (ARVN)
Cacace Angela M — Chief Scientific Officer
Shares
1,038
Price
$12.16
Total Value
$12.62K
Shares Held After
150,194
% of Holdings
0.7%
ARVINAS, INC. (ARVN)
Loomis David K — Chief Accounting Officer
Shares
1,108
Price
$12.16
Total Value
$13.47K
Shares Held After
29,692
% of Holdings
3.6%
Moderna, Inc. (MRNA)
Hoge Stephen — President
Shares
160,009
Price
$48.84
Total Value
$7.81M
Shares Held After
1,457,427
% of Holdings
9.9%
Showing 1801–1850 of 3687 transactions (page 37 of 74)